Finance

Lists
Q2 2026 earnings • released • Revenue beat +7.88%
See results
IDIA:SWX
Idorsia Ltd
CHF 5.59
-8.59%
(-0.52) 1D
Aug 3, 2:07:56 PM GMT+2  ·   CHF
All symbols
SymbolPriceChange% Change
Generating top insights for IDIA...
Open
CHF 6.10
High
CHF 6.12
Low
CHF 5.58
Mkt. cap
1.47B
Avg. vol.
1.56M
Volume
1.85M
52-wk high
CHF 7.56
52-wk low
CHF 2.42
EPS
-CHF 1.28
Shares outstanding
263.06M
No. of employees
456
Open
CHF 6.10
High
CHF 6.12
Low
CHF 5.58
Mkt. cap
1.47B
Avg. vol.
1.56M
Volume
1.85M
52-wk high
CHF 7.56
52-wk low
CHF 2.42
EPS
-CHF 1.28
Shares outstanding
263.06M
No. of employees
456
News stories
From sources across the web
Profile
Idorsia is a Swiss pharmaceutical research company in Allschwil, near Basel, Switzerland. Wikipedia
About Idorsia Ltd
CEO-
Employees456
Founded2017
Headquarters-
SectorBiotechnology
Websiteidorsia.com
Last report
Jul 30, 2026
Fiscal period
Q2 2026
EPS / Est. (CHF)
- / -
Revenue / Est. (CHF)
52.86M / 49.00M
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in CHF
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CHF
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
41.49M
47.97M
57.39M
52.86M
Cost of goods sold
30.25M
36.94M
31.81M
-12.88M
Cost of revenue
30.25M
36.94M
31.81M
-12.88M
Research and development expenses
-
-
-
50.61M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
54.47M
63.45M
51.46M
50.06M
Operating expense
51.43M
62.84M
52.11M
102.04M
Total operating expenses
81.67M
99.78M
83.92M
89.16M
Operating income
-40.19M
-51.81M
-26.53M
-36.30M
Other non operating income
14.54M
-31.45M
-451.00K
-749.00K
EBT including unusual items
-85.50M
-75.91M
-46.18M
-105.97M
EBT excluding unusual items
-50.34M
-65.08M
-46.32M
-58.91M
Income tax expense
180.00K
1.85M
-486.00K
1.08M
Effective tax rate
-0.21%
-2.44%
1.05%
-1.02%
Other operating expenses
-4.55M
-2.19M
-653.00K
-53.00K
Net income
-85.68M
-77.76M
-45.70M
-107.05M
Net profit margin
-206.52%
-162.09%
-79.62%
-202.52%
Earnings per share
-
-
-
-
Interest and investment income
-
9.48M
-
-
Interest expense
-15.39M
-
-19.35M
-21.86M
Net interest expenses
-15.39M
9.48M
-19.35M
-21.86M
Depreciation and amortization charges
-
-
-
-
EBITDA
-36.04M
-47.78M
-22.77M
-32.43M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps